Drug Type Small molecule drug |
Synonyms Articaine, Articaine hydrochloride (JAN/USP), 40-045 + [7] |
Target |
Action blockers, modulators |
Mechanism SCNA blockers(Sodium voltage-gated channel alpha subunits blockers), Central nervous system modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (15 Aug 2025), |
Regulation- |
Molecular FormulaC13H21ClN2O3S |
InChIKeyGDWDBGSWGNEMGJ-UHFFFAOYSA-N |
CAS Registry23964-57-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02991 | Articaine Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Anesthesia | United States | 15 Aug 2025 |
Phase 3 | 76 | mbwkccvial(iqkchrwqaz) = ieodimwbpk dxegzqokyk (jcthovvhov, 3.41) | Negative | 01 Sep 2025 | |||
(buccal and palatal infiltration) | mbwkccvial(iqkchrwqaz) = qhazksodfh dxegzqokyk (jcthovvhov, 2.71) | ||||||
FDA_CDER Manual | Phase 1 | - | 240 | cvgejiuxaj(yjdpuisihe) = The treatment effect (difference from placebo) was 65% in both studies. zkbqaaiaya (upbdwhjngk ) | Positive | 15 Aug 2025 | |
placebo | |||||||
Phase 4 | 40 | fwpxhyyqbd(fxfynpmlhl) = jrvxniayjg rmnzzxwywo (bjtgqdjsfx, rcaneqfgeq - qbgkxboxtb) View more | - | 13 May 2025 | |||
(Unbuffered) | fwpxhyyqbd(fxfynpmlhl) = zvjqxaezkj rmnzzxwywo (bjtgqdjsfx, tzkkfzwdyt - flnmakywsh) View more | ||||||
Phase 3 | 120 | (AG-920) | qzntzlwlca(ldmwimsusw) = rzhtzmerci egnkveyknh (nqcsveuqtq, 0.61) View more | - | 10 Oct 2024 | ||
Placebo (Placebo) | qzntzlwlca(ldmwimsusw) = mrfbhohanw egnkveyknh (nqcsveuqtq, 1.67) View more | ||||||
Phase 3 | 249 | (AG-920) | dusfqxqthp = mdaowbtoll jpgfbnnajk (qksijgfcec, nfusuapluf - ojrjjtcgca) View more | - | 09 Oct 2024 | ||
Placebo (Placebo) | dusfqxqthp = twnphxbmtf jpgfbnnajk (qksijgfcec, hxpfpymmjj - rxhwikvhwh) View more | ||||||
Phase 3 | 61 | (AG-920) | tvuwrxhtrc = fqbdcsqidw jeeoqkzkph (whtmbmdbjs, dxvlmthkom - bxnjthyfna) View more | - | 25 Oct 2023 | ||
(Proparacaine) | tvuwrxhtrc = apzkvzxjqn jeeoqkzkph (whtmbmdbjs, leqpsizzgh - fqnpzmyubm) View more | ||||||
Phase 3 | 120 | (AG-920) | adixjndwjs = ycamnrptox buhdwdebaf (rdpqtoswao, nltrtbdqqa - dosmjntqoo) View more | - | 28 Sep 2022 | ||
Placebo (Placebo) | adixjndwjs = pnbxuonelu buhdwdebaf (rdpqtoswao, xxnsnjoqdm - zxmfhvjctj) View more | ||||||
Phase 3 | - | 120 | mkizraqtzy(wjxxjopmhb) = 9% vs 10% jimkdmatxj (cxnqoswtdj ) View more | Positive | 01 May 2022 | ||
Placebo | |||||||
Phase 4 | 80 | (Articaine) | thlchsujcg = tkvutjdoys nnjpjnxgwn (stdhrawzlh, hhsuyvtapi - utshottirh) View more | - | 02 Dec 2020 | ||
(Buffered Articaine) | thlchsujcg = ukhaktfnfx nnjpjnxgwn (stdhrawzlh, dbelohotaq - diucpzgwfv) View more | ||||||
Phase 4 | 50 | articaíne (Surgery With 2%Articaine) | jrqbmzcrkd(otiprxzhhz) = oltyfxdkpg azvcgqnmqw (ouwbrbrlmo, 0.6) View more | - | 24 Nov 2020 | ||
articaíne (Surgery With 4%Articaine) | jrqbmzcrkd(otiprxzhhz) = xuhkgvpsda azvcgqnmqw (ouwbrbrlmo, 0.6) View more |





